AnalystsBill Maughan
Bill Maughan's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4828 out of 5263 analysts
Average Return
-10.2%
Win Rate
32%6 out of 19
Risk vs Reward
Poor
Good

Bill Maughan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Merus NvMRUS
+129.26%$21.94$50.30
2023-11-01 -
2024-11-01
Strong Buy
Dianthus Therapeutics IncDNTH
+115.20%$38.88$83.67
2025-09-16 -
2026-04-28
Strong Buy
Krystal Biotech IncKRYS
+93.71%$139.01$269.27
2025-06-30 -
2026-04-28
Strong Buy
Annexon IncANNX
+47.78%$4.06$6.00
2025-12-01 -
2026-04-28
Strong Buy
Caribou Biosciences IncCRBU
+42.47%$1.46$2.08
2026-02-02 -
2026-04-28
Strong Buy

Bill Maughan Analyst Color

Get additional color on Bill Maughan's coverage of popular stocks

Bill Maughan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dianthus Therapeutics IncDNTH
2Strong Buy$130.00+55.37%Maintains
2 months ago
Ocular Therapeutix IncOCUL
1Strong Buy$28.00+200.43%Maintains
2 months ago
Korro Bio IncKRRO
2Strong Buy$18.00+40.63%Upgrades
2 months ago
Caribou Biosciences IncCRBU
1Strong Buy$13.00+525.00%Initiates Coverage On
3 months ago
Cellectis SaCLLS
1Strong Buy$9.00+125.00%Initiates Coverage On
4 months ago
Wave Life Sciences LtdWVE
2Strong Buy$47.00+525.00%Maintains
5 months ago
Annexon IncANNX
1Strong Buy$17.00+183.33%Initiates Coverage On
5 months ago
Y Mabs Therapeutics IncYMAB
3Hold$8.60-0.12%Downgrades
9 months ago
Krystal Biotech IncKRYS
1Strong Buy$190.00-29.44%Initiates Coverage On
10 months ago
Crispr Therapeutics AgCRSP
1Hold$45.00-13.56%Downgrades
10 months ago
Nkarta IncNKTX
2Strong Buy$15.00N/AMaintains
2 years ago
Fate Therapeutics IncFATE
1Strong Buy$9.00N/AMaintains
2 years ago
Immunocore Holdings PLCIMCR
3Hold$67.00N/AMaintains
2 years ago
Moderna IncMRNA
3Hold$106.00N/AMaintains
2 years ago
Century Therapeutics IncIPSC
1Strong Buy$24.00N/AMaintains
2 years ago
Bicycle Therapeutics PLCBCYC
1Strong Buy$60.00N/AReiterates
2 years ago
Merus NvMRUS
1Strong Buy$45.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.